Jeong, S.Y., Lee, S.-W., Kim, W.W., Jung, J.H., Lee, W.K., Ahn, B.-C. and Lee, J. (2019) Clinical Outcomes of Patients with T4 or N1b Well-Differentiated Thyroid Cancer after Different Strategies of Adjuvant Radioiodine Therapy. Scientific Reports, 9, 5570.
https://doi.org/10.1038/s41598-019-42083-3

has been cited by the following article:

• TITLE: Progress in Research on 5-HTTLPR under Stress and Thyroid Papillary Carcinoma

  AUTHORS: Liumei Luo, Juncheng Guo, Fengxia Chen, Min Guo, Ping Huang

  KEYWORDS: 5-HTTLPR, Hyroid Papillary Carcinoma, Central Nervous System, Clinical Diagnosis, Treatment

  JOURNAL NAME: Journal of Behavioral and Brain Science, Vol.9 No.9, September 11, 2019

  ABSTRACT: The central nervous system plays an important role in regulating thyroid hormone homeostasis. 5-HT is one of the important neurotransmitters involved in energy balance regulation. 5-HT transporters affect 5-HT function by regulating SERT protein expression and transcriptional activity. Based on the biological correlation between thyroid hormone and thyroid tumors, 5-HTTLPR is associated with thyroid tumors under stress. Animal models of thyroid disease have shown that some of the transmitters in the brain’s monoaminergic nervous system have changed, and when the monoamine transporter gene expression is altered, it is found that this disorder is more pronounced. This article discusses whether thyroid papillary carcinoma patients are associated with 5-HTTLPR and whether the mechanism of thyroid papillary carcinoma “gene x environment” has an effect. Briefly describe the role of 5-HTTLPR in the development of patients with papillary thyroid carcinoma, and provide a basis for clinical diagnosis and treatment of papillary thyroid cancer.